SI2547364T1 - Peptidi, konjugati in postopek za povečanje imunogenosti cepiva - Google Patents

Peptidi, konjugati in postopek za povečanje imunogenosti cepiva

Info

Publication number
SI2547364T1
SI2547364T1 SI201131107A SI201131107A SI2547364T1 SI 2547364 T1 SI2547364 T1 SI 2547364T1 SI 201131107 A SI201131107 A SI 201131107A SI 201131107 A SI201131107 A SI 201131107A SI 2547364 T1 SI2547364 T1 SI 2547364T1
Authority
SI
Slovenia
Prior art keywords
conjugates
vaccine
peptides
increasing immunogenicity
immunogenicity
Prior art date
Application number
SI201131107A
Other languages
English (en)
Inventor
Ferdinand Antonius Ossendorp
Cornelis Joseph Maria Melief
Jan Wouter Drijfhout
Original Assignee
Academisch Ziekenhuis Leiden H.O.D.N. Lumc
Stichting Voor De Technische Wetenschappen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academisch Ziekenhuis Leiden H.O.D.N. Lumc, Stichting Voor De Technische Wetenschappen filed Critical Academisch Ziekenhuis Leiden H.O.D.N. Lumc
Publication of SI2547364T1 publication Critical patent/SI2547364T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SI201131107A 2010-03-15 2011-03-15 Peptidi, konjugati in postopek za povečanje imunogenosti cepiva SI2547364T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP10156505 2010-03-15
US31793010P 2010-03-26 2010-03-26
PCT/NL2011/050180 WO2011115483A1 (en) 2010-03-15 2011-03-15 Peptides, conjugates and method for increasing immunogenicity of a vaccine
EP11712343.0A EP2547364B1 (en) 2010-03-15 2011-03-15 Peptides, conjugates and method for increasing immunogenicity of a vaccine

Publications (1)

Publication Number Publication Date
SI2547364T1 true SI2547364T1 (sl) 2017-05-31

Family

ID=43430699

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201131107A SI2547364T1 (sl) 2010-03-15 2011-03-15 Peptidi, konjugati in postopek za povečanje imunogenosti cepiva

Country Status (15)

Country Link
US (1) US9522962B2 (sl)
EP (1) EP2547364B1 (sl)
CN (1) CN102892431A (sl)
CA (1) CA2793087C (sl)
CY (1) CY1118801T1 (sl)
DK (1) DK2547364T3 (sl)
ES (1) ES2616258T3 (sl)
HR (1) HRP20170251T1 (sl)
HU (1) HUE031924T2 (sl)
LT (1) LT2547364T (sl)
PL (1) PL2547364T3 (sl)
PT (1) PT2547364T (sl)
RS (1) RS55670B1 (sl)
SI (1) SI2547364T1 (sl)
WO (1) WO2011115483A1 (sl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2946010B1 (en) 2013-01-18 2018-08-29 London School of Hygiene and Tropical Medicine Glycosylation method
GB201301085D0 (en) * 2013-01-22 2013-03-06 London School Hygiene & Tropical Medicine Glycoconjugate Vaccine
EP3119432B1 (en) * 2014-03-19 2020-01-08 MacKay Medical Foundation the Presbyterian Church in Taiwan MacKay Memorial Hospital Antibodies against immunogenic glycopeptides, composition comprising the same and use thereof
CN106986923B (zh) * 2017-04-10 2021-01-26 新疆农垦科学院 GnRH抗原及其在主动免疫对公牛的去势效果及肉品质影响中的应用
MX2020010621A (es) 2018-04-10 2020-10-20 Ac Immune Sa Vacunas terapeuticas anti-abeta.
EP3830110A4 (en) * 2018-07-31 2022-03-02 Snoretox Pty Ltd PEGYLATED TETANUS NEUROTOXINS AND THE TREATMENT OF HYPOTONIA
WO2020104690A1 (en) 2018-11-23 2020-05-28 Quine Medical Ab Bi-specific conjugates
GB201917699D0 (en) 2019-12-04 2020-01-15 Ultimovacs Ab Vaccine conjugates
US20230057367A1 (en) * 2020-02-03 2023-02-23 Snoretox Ltd Composition and method
CN113318225B (zh) * 2020-02-28 2024-01-19 无锡派列博生物医药科技有限公司 肿瘤免疫增强剂及其制法和应用
GB202008003D0 (en) 2020-05-28 2020-07-15 Quine Medical Ab Anti-CD40 antibody
WO2022087122A1 (en) * 2020-10-20 2022-04-28 Longhorn Vaccines And Diagnostics, Llc Immunogenic antigens
EP4301406A1 (en) * 2021-03-04 2024-01-10 Longhorn Vaccines and Diagnostics, LLC Vaccines for the treatment and prevention of zoonotic infections
EP4351634A2 (en) * 2021-06-09 2024-04-17 Ultimovacs AB A conjugate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
EP0737205A1 (en) * 1993-12-28 1996-10-16 Chiron Mimotopes Pty. Ltd. T-cell epitopes
JP4229341B2 (ja) * 1996-03-23 2009-02-25 財団法人阪大微生物病研究会 破傷風毒素の機能的フラグメント抗原及び破傷風ワクチン
EP0971747B1 (en) 1996-10-28 2005-12-28 Amersham Health AS Contrast agents
US6180084B1 (en) 1998-08-25 2001-01-30 The Burnham Institute NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same
FR2806727A1 (fr) * 2000-03-23 2001-09-28 Pf Medicament Molecule d'interet pharmaceutique comprotant en son extremite n-terminale un acide glutamique ou une glutamine sous forme de sel d'addition d'acide fort physiologiquement acceptable
US6372250B1 (en) 2000-04-25 2002-04-16 The Regents Of The University Of California Non-invasive gene targeting to the brain
CA2431500C (en) 2000-12-08 2016-06-07 Sjoerd Hendrikus Van Der Burg Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
US20040101534A1 (en) 2002-06-25 2004-05-27 Diamond Don J. Adjuvant-free peptide vaccine
US9662383B2 (en) 2007-03-26 2017-05-30 University Of Massachusetts Compositions and methods for increasing immunogenicity of glycoprotein vaccines

Also Published As

Publication number Publication date
EP2547364B1 (en) 2016-12-14
LT2547364T (lt) 2017-03-27
RS55670B1 (sr) 2017-06-30
US20130071428A1 (en) 2013-03-21
HUE031924T2 (en) 2017-08-28
DK2547364T3 (en) 2017-02-27
CN102892431A (zh) 2013-01-23
CA2793087A1 (en) 2011-09-22
CA2793087C (en) 2019-07-23
HRP20170251T1 (hr) 2017-04-21
PL2547364T3 (pl) 2017-06-30
CY1118801T1 (el) 2018-01-10
ES2616258T3 (es) 2017-06-12
EP2547364A1 (en) 2013-01-23
US9522962B2 (en) 2016-12-20
PT2547364T (pt) 2017-02-21
WO2011115483A1 (en) 2011-09-22

Similar Documents

Publication Publication Date Title
RS55670B1 (sr) Peptidi, konjugati i metod za povećanje imunogenosti vakcine
IL222691A0 (en) Antibodies having reduced immunogenicity in a human
EP2429585A4 (en) VACCINE IMMUNOTHERAPY
IL223206A0 (en) Vaccine formulations
EP2529227A4 (en) IMMUNOGENIC PREPARATIONS BASED ON CYTOMEGALOVIRUS
ZA201201714B (en) Protein matrix vaccines of improved immunogenicity
HK1212358A1 (en) Grass peptides for vaccine
GB201002559D0 (en) Birch peptides for vaccine
EP2543387A4 (en) MUCOSAL VACCINE
EP2482843A4 (en) PROCESS FOR IMPROVED VACCINE IMMUNOGENICITY
EP2484757A4 (en) VIRUS FOR THE EXPRESSION OF ALPHA GALACTOSE EPITOPES AND METHOD FOR THE PRODUCTION OF A VACCINE
GB0900455D0 (en) Vaccine
GB0918782D0 (en) A protein as an adjuvant for a vaccine
GB201013006D0 (en) Vaccine
GB201006324D0 (en) Vaccine
ZA201302154B (en) Vaccine
GB201001624D0 (en) Peptides for vaccine
GB0917871D0 (en) Peptides for vaccine
GB0901928D0 (en) Peptides for vaccine
GB0902344D0 (en) Peptides for vaccine
GB0902345D0 (en) Peptides for vaccine
GB201010058D0 (en) Peptide vaccine
GB201010056D0 (en) Polypeptide vaccine
GB201012283D0 (en) Vaccine
GB201007589D0 (en) Vaccine